IndraLab

Statements


KCNH2-N588K inhibits SQT1. 1 / 1
| 1

reach
"The attenuated inactivation N588K HERG mutant used in this study has been shown recently to underlie the SQT1 familial form of the recently identified genetic ' Short QT syndrome ', which carries a risk of cardiac arrhythmia and sudden death XREF_BIBR."